| __timestamp | Agios Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 14182353 |
| Thursday, January 1, 2015 | 141827000 | 15503028 |
| Friday, January 1, 2016 | 220163000 | 16183585 |
| Sunday, January 1, 2017 | 292681000 | 22382849 |
| Monday, January 1, 2018 | 341324000 | 33038206 |
| Tuesday, January 1, 2019 | 410894000 | 31777040 |
| Wednesday, January 1, 2020 | 367470000 | 41464134 |
| Friday, January 1, 2021 | 256973000 | 67178053 |
| Saturday, January 1, 2022 | 279910000 | 52531000 |
| Sunday, January 1, 2023 | 288903000 | 68914000 |
| Monday, January 1, 2024 | 301286000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Agios Pharmaceuticals, Inc. has consistently outpaced Pharming Group N.V. in R&D spending, with Agios investing nearly 7 times more on average. From 2014 to 2023, Agios's R&D expenses peaked in 2019, marking a 310% increase from 2014, while Pharming's highest expenditure was in 2023, showing a 386% rise from its 2014 figures. This trend highlights Agios's aggressive pursuit of groundbreaking therapies, while Pharming's steady growth reflects a more conservative approach. As the pharmaceutical landscape continues to shift, these investment strategies will play a crucial role in shaping the future of healthcare innovation.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.